Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02674386 · ClinicalTrials.gov registry record · Phase 3
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
A Phase 3 study of Osteoarthritis, sponsored by Pfizer.
- Completed
- Registry status
- Phase 3
- Development phase
- 154
- Enrollment target
- 20
- Study locations
NCT02674386 is a Phase 3 study of Osteoarthritis that has completed, run by Pfizer. The registered enrollment target is 154 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (81% lower). The trial reports 20 study locations across 6 states.
The verdict
NCT02674386, a Phase 3 study of Osteoarthritis, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 154 participants
- Enrollment target
- 20
- Study locations
Study Summary
A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 weeks after the total joint replacement surgery. There will be two methods of data collection utilized in this study: interview by site staff via the telephone and interactive web-response system (or paper if the subject has no access to the internet).
Conditions Studied
Interventions
- DRUG Investigational Medical Product (IMP) administered in parent study
Study Locations (20)
California
- Advanced Research Center, Inc. - Anaheim
- Hope Clinical Research - Canoga Park
- Marvel Clinical Research, LLC - Huntington Beach
- Advances in Medicine - Palm Desert
- Clinical Trials Research - Sacramento
- California Research Foundation - San Diego
- CITrials - Santa Ana
Florida
- JEM Research Institute - Atlantis
- Orthopedic Research Institute - Boynton Beach
- Orthopaedic Associates of West Florida - Clearwater
- Clinical Neuroscience Solutions, Inc. - Jacksonville
- Clintex Research Group - Miami
- Renstar Medical Research - Ocala
Alabama
- Central Alabama Research - Birmingham
- Alabama Clinical Therapeutics, LLC - Birmingham
- Alabama Orthopaedic Surgeons - Birmingham
- Cahaba Research Inc. - Birmingham
Arizona
- Noble Clinical Research - Tucson
Arkansas
- Baptist Health Center for Clinical Research - Little Rock
Connecticut
- Stamford Therapeutics Consortium - Stamford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2016-08-23 |
| Est. Completion | 2019-07-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02674386
The ClinicalTrials.gov registry entry for NCT02674386 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (81% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Investigational Medical Product (IMP) administered in parent study is the first listed.
NCT02674386 reports 20 study locations spanning 6 distinct geographic areas - top geographies include California, Florida, Alabama.
Frequently Asked Questions
What is clinical trial NCT02674386 about?
NCT02674386 is a clinical study titled "Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement". A4091064 is a multicenter, long-term observational study of subjects from tanezumab interventional studies (regardless of treatment group) who undergo a total knee, hip or shoulder replacement during participation in the study. The study is designed with a total duration of subject follow-up of 24 w...
What is the current status of trial NCT02674386?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 154 participants. The study started on 2016-08-23. Estimated completion is 2019-07-15.
What conditions does trial NCT02674386 study?
This clinical trial studies the following conditions: Osteoarthritis.
What interventions are being tested in trial NCT02674386?
The interventions under investigation include: Investigational Medical Product (IMP) administered in parent study (DRUG).
Who is sponsoring clinical trial NCT02674386?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02674386 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Beat Pain Better Trial
RECRUITING · Phase 3
-
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
RECRUITING · Phase 3
-
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee
RECRUITING · Phase 3
-
Allograft Transplantation in the Treatment of Osteoarthritis of the Metatarsophalangeal (MTP) Joint of the Great Toe
COMPLETED · Phase 3
-
Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis
COMPLETED · Phase 3
-
Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial I
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.